Published in Neuroreport on February 08, 2005
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet (2006) 2.53
Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS One (2008) 2.40
Prospects for epigenetic epidemiology. Am J Epidemiol (2009) 2.00
Genetic approaches to addiction: genes and alcohol. Addiction (2008) 1.70
Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol (2008) 1.53
Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna) (2006) 1.43
Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease. Nucleic Acids Res (2008) 1.40
Neuroscience of alcoholism: molecular and cellular mechanisms. Cell Mol Life Sci (2009) 1.32
Epigenetic effects of ethanol on liver and gastrointestinal injury. World J Gastroenterol (2006) 1.29
The impact of recent alcohol use on genome wide DNA methylation signatures. Front Genet (2012) 1.28
Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology (2008) 1.23
Review. Neurogenetic studies of alcohol addiction. Philos Trans R Soc Lond B Biol Sci (2008) 1.21
DNA methylation impacts on learning and memory in aging. Neurobiol Aging (2007) 1.20
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci (2010) 1.16
Behavioral epigenetics. Ann N Y Acad Sci (2011) 1.14
Chromatin remodeling--a novel strategy to control excessive alcohol drinking. Transl Psychiatry (2013) 1.11
Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res (2012) 1.09
Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcohol Clin Exp Res (2008) 1.04
Subtle decreases in DNA methylation and gene expression at the mouse Igf2 locus following prenatal alcohol exposure: effects of a methyl-supplemented diet. Alcohol (2010) 1.04
Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Hum Genet (2010) 1.00
N-methyl-D-aspartate 2b receptor subtype (NR2B) promoter methylation in patients during alcohol withdrawal. J Neural Transm (Vienna) (2009) 0.98
Genetic risk prediction and neurobiological understanding of alcoholism. Transl Psychiatry (2014) 0.97
A pilot examination of the genome-wide DNA methylation signatures of subjects entering and exiting short-term alcohol dependence treatment programs. Epigenetics (2014) 0.97
Genetics and epigenetics of Parkinson's disease. ScientificWorldJournal (2012) 0.95
Epigenetics-beyond the genome in alcoholism. Alcohol Res (2012) 0.94
DNA methylation, a hand behind neurodegenerative diseases. Front Aging Neurosci (2013) 0.94
How the epigenome contributes to the development of psychiatric disorders. Dev Psychobiol (2010) 0.92
The epigenetic landscape of alcoholism. Int Rev Neurobiol (2014) 0.91
Epigenetics of drug abuse: predisposition or response. Pharmacogenomics (2012) 0.91
Epigenetic control of gene expression in the alcoholic brain. Alcohol Res (2013) 0.89
Determination of Methylated CpG Sites in the Promoter Region of Catechol-O-Methyltransferase (COMT) and their Involvement in the Etiology of Tobacco Smoking. Front Psychiatry (2010) 0.87
Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. J Hum Genet (2012) 0.86
Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities. Neurotherapeutics (2013) 0.85
Genetic research: who is at risk for alcoholism. Alcohol Res Health (2010) 0.85
Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background. Eur J Neurosci (2011) 0.84
Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug Alcohol Depend (2007) 0.84
DNA methylation patterns in alcoholics and family controls. World J Gastrointest Oncol (2012) 0.84
Ethanol-induced Htr3a promoter methylation changes in mouse blood and brain. Alcohol Clin Exp Res (2012) 0.84
Genetics and epigenetics of alcohol dependence. J Mol Psychiatry (2013) 0.84
Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders. Genes (Basel) (2015) 0.83
Epigenetic mechanisms are involved in the regulation of ethanol consumption in mice. Int J Neuropsychopharmacol (2014) 0.80
Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells. BMC Cancer (2014) 0.80
DNA co-methylation modules in postmortem prefrontal cortex tissues of European Australians with alcohol use disorders. Sci Rep (2016) 0.79
Molecular basis of alcoholism. Handb Clin Neurol (2014) 0.78
Brain plasticity and cognitive functions after ethanol consumption in C57BL/6J mice. Transl Psychiatry (2015) 0.76
Alcohol-dose-dependent DNA methylation and expression in the nucleus accumbens identifies coordinated regulation of synaptic genes. Transl Psychiatry (2017) 0.76
A Framework to Examine the Role of Epigenetics in Health Disparities among Native Americans. Nurs Res Pract (2013) 0.76
Frequency of alcohol consumption in humans; the role of metabotropic glutamate receptors and downstream signaling pathways. Transl Psychiatry (2015) 0.76
Genome-wide analysis of the nucleus accumbens identifies DNA methylation signals differentiating low/binge from heavy alcohol drinking. Alcohol (2016) 0.76
Emerging role of epigenetic mechanisms in alcohol addiction. Alcohol Clin Exp Res (2017) 0.75
An Exploratory Association Study of Alcohol Use Disorder and DNA Methylation. Alcohol Clin Exp Res (2016) 0.75
Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity. Biomed Res Int (2016) 0.75
Alcohol and nicotine codependence-associated DNA methylation changes in promoter regions of addiction-related genes. Sci Rep (2017) 0.75
DNA modifications in models of alcohol use disorders. Alcohol (2016) 0.75
A Study on MTHFR C677T Gene Polymorphism and Alcohol Dependence among Meiteis of Manipur, India. J Biomark (2014) 0.75
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res (2010) 2.45
Socioeconomic status and depression during and after pregnancy in the Franconian Maternal Health Evaluation Studies (FRAMES). Arch Gynecol Obstet (2013) 2.06
Managing an effective treatment for neuroleptic malignant syndrome. Crit Care (2007) 1.73
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry (2009) 1.64
Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides. Clin Chem (2006) 1.54
Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs. Neuron (2012) 1.51
Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res (2006) 1.51
Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease. J Alzheimers Dis (2009) 1.49
Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau. Neurobiol Aging (2004) 1.48
Repetitive transcranial magnetic stimulation influences mood in healthy male volunteers. J Psychiatr Res (2011) 1.46
Drug-induced psychosis after long-term treatment with levetiracetam. Can J Psychiatry (2004) 1.46
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med (2013) 1.36
Therapeutic approaches to Alzheimer's disease. Brain (2006) 1.34
Estimated prevalence of compulsive buying in Germany and its association with sociodemographic characteristics and depressive symptoms. Psychiatry Res (2010) 1.33
Global DNA methylation is influenced by smoking behaviour. Eur Neuropsychopharmacol (2008) 1.29
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem (2007) 1.28
Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides. Electrophoresis (2004) 1.27
International quality control survey of neurochemical dementia diagnostics. Neurosci Lett (2006) 1.26
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain (2006) 1.25
Non-drug therapies for dementia: an overview of the current situation with regard to proof of effectiveness. Dement Geriatr Cogn Disord (2003) 1.17
Association of SORL1 gene variants with Alzheimer's disease. Brain Res (2009) 1.14
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J Med Chem (2007) 1.13
Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature. J Mol Neurosci (2004) 1.13
Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease. J Neural Transm (Vienna) (2009) 1.10
Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. J Psychiatr Res (2008) 1.10
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging (2007) 1.10
Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J Neural Transm (Vienna) (2010) 1.09
Mild cognitive impairment: incidence and risk factors: results of the leipzig longitudinal study of the aged. J Am Geriatr Soc (2010) 1.07
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats. Brain (2013) 1.07
Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease. Neurosci Lett (2008) 1.04
Daily variations of homocysteine concentration may influence methylation of DNA in normal healthy individuals. Chronobiol Int (2007) 1.03
Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls. J Cereb Blood Flow Metab (2010) 1.03
Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma (2007) 1.02
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis (2012) 1.02
Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann Neurol (2003) 1.02
Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving. Alcohol Clin Exp Res (2005) 1.01
Epigenetics and depression: current challenges and new therapeutic options. Curr Opin Psychiatry (2010) 1.01
Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease. Biol Psychiatry (2004) 1.01
Ghrelin levels are increased in alcoholism. Alcohol Clin Exp Res (2005) 1.00
Elevated alpha synuclein mRNA levels are associated with craving in patients with alcoholism. Biol Psychiatry (2004) 1.00
Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study. J Neural Transm (Vienna) (2012) 0.99
Epigenetic dysregulation of dopaminergic genes in eating disorders. Int J Eat Disord (2010) 0.99
Quantitative modeling of selective lysosomal targeting for drug design. Eur Biophys J (2008) 0.99
Predictors of binge drinking in adolescents: ultimate and distal factors - a representative study. BMC Public Health (2012) 0.98
N-methyl-D-aspartate 2b receptor subtype (NR2B) promoter methylation in patients during alcohol withdrawal. J Neural Transm (Vienna) (2009) 0.98
Cerebrospinal fluid leakage--reliable diagnostic methods. Clin Chim Acta (2011) 0.98
DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence. J Neural Transm (Vienna) (2010) 0.97
Secretory sphingomyelinase in health and disease. Biol Chem (2015) 0.97
Microstructural abnormalities of the posterior thalamic radiation and the mediodorsal thalamic nuclei in females with anorexia nervosa--a voxel based diffusion tensor imaging (DTI) study. J Psychiatr Res (2012) 0.97
Cortical activity associated with auditory hallucinations. Neuroreport (2004) 0.96
Blood-based neurochemical diagnosis of vascular dementia: a pilot study. J Neurochem (2007) 0.96
Low digit ratio 2D:4D in alcohol dependent patients. PLoS One (2011) 0.96
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Motives for khat use and abstinence in Yemen--a gender perspective. BMC Public Health (2010) 0.96
Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species. Proteomics (2007) 0.96
Alcohol consumption and binge drinking in adolescents: comparison of different migration backgrounds and rural vs. urban residence--a representative study. BMC Public Health (2011) 0.96
Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers. J Alzheimers Dis (2011) 0.96
Systematic heterogeneity of fractional vesicle pool sizes and release rates of hippocampal synapses. Biophys J (2011) 0.96
CNS BOLD fMRI effects of sham-controlled transcutaneous electrical nerve stimulation in the left outer auditory canal - a pilot study. Brain Stimul (2013) 0.96
Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry (2003) 0.95
C677T variant in the methylentetrahydrofolate reductase gene is a genetic risk factor for primary open-angle glaucoma. Am J Ophthalmol (2005) 0.95
Preanalytical sample handling and sample stability testing for the neurochemical dementia diagnostics. J Alzheimers Dis (2011) 0.95
The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide. Rapid Commun Mass Spectrom (2003) 0.95
Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res (2010) 0.95
Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons. Brain Res (2005) 0.95
Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis. Eur Neuropsychopharmacol (2006) 0.95
Transient increase of plasma concentrations of amyloid β peptides after electroconvulsive therapy. Brain Stimul (2011) 0.94
Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol (2004) 0.94
Sex hormone activity in alcohol addiction: integrating organizational and activational effects. Prog Neurobiol (2011) 0.94
Promoter specific DNA methylation and gene expression of POMC in acutely underweight and recovered patients with anorexia nervosa. J Psychiatr Res (2010) 0.93
Key physiological parameters dictate triggering of activity-dependent bulk endocytosis in hippocampal synapses. PLoS One (2012) 0.93
Tranylcypromine: new perspectives on an "old" drug. Eur Arch Psychiatry Clin Neurosci (2006) 0.93
Low 2D:4D values are associated with video game addiction. PLoS One (2013) 0.93
The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res (2010) 0.93
Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomizied, controlled trial. BMC Med (2011) 0.92
Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system. J Cell Physiol (2010) 0.92
Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype. J Alzheimers Dis (2010) 0.91